Oral Peptide Therapy Market
1 Oral Peptide Therapy Market Overview
1.1 Product Overview and Scope of Oral Peptide Therapy
1.2 Oral Peptide Therapy Segment by Type
1.2.1 Global Oral Peptide Therapy Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Oral Peptide Therapy Segment by Application
1.3.1 Global Oral Peptide Therapy Sales Comparison by Application: (2022-2028)
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Global Oral Peptide Therapy Market Size Estimates and Forecasts
1.4.1 Global Oral Peptide Therapy Revenue 2017-2028
1.4.2 Global Oral Peptide Therapy Sales 2017-2028
1.4.3 Oral Peptide Therapy Market Size by Region: 2017 Versus 2021 Versus 2028
2 Oral Peptide Therapy Market Competition by Manufacturers
2.1 Global Oral Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
2.2 Global Oral Peptide Therapy Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Oral Peptide Therapy Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Oral Peptide Therapy Manufacturing Sites, Area Served, Product Type
2.5 Oral Peptide Therapy Market Competitive Situation and Trends
2.5.1 Oral Peptide Therapy Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Oral Peptide Therapy Players Market Share by Revenue
2.5.3 Global Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Peptide Therapy Retrospective Market Scenario by Region
3.1 Global Oral Peptide Therapy Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Oral Peptide Therapy Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Oral Peptide Therapy Market Facts & Figures by Country
3.3.1 North America Oral Peptide Therapy Sales by Country
3.3.2 North America Oral Peptide Therapy Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Oral Peptide Therapy Market Facts & Figures by Country
3.4.1 Europe Oral Peptide Therapy Sales by Country
3.4.2 Europe Oral Peptide Therapy Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oral Peptide Therapy Market Facts & Figures by Region
3.5.1 Asia Pacific Oral Peptide Therapy Sales by Region
3.5.2 Asia Pacific Oral Peptide Therapy Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Oral Peptide Therapy Market Facts & Figures by Country
3.6.1 Latin America Oral Peptide Therapy Sales by Country
3.6.2 Latin America Oral Peptide Therapy Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Oral Peptide Therapy Market Facts & Figures by Country
3.7.1 Middle East and Africa Oral Peptide Therapy Sales by Country
3.7.2 Middle East and Africa Oral Peptide Therapy Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Oral Peptide Therapy Historic Market Analysis by Type
4.1 Global Oral Peptide Therapy Sales Market Share by Type (2017-2022)
4.2 Global Oral Peptide Therapy Revenue Market Share by Type (2017-2022)
4.3 Global Oral Peptide Therapy Price by Type (2017-2022)
5 Global Oral Peptide Therapy Historic Market Analysis by Application
5.1 Global Oral Peptide Therapy Sales Market Share by Application (2017-2022)
5.2 Global Oral Peptide Therapy Revenue Market Share by Application (2017-2022)
5.3 Global Oral Peptide Therapy Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Allergan Oral Peptide Therapy Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Corporation Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Novo Nordisk Oral Peptide Therapy Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Synergy Pharmaceuticals ?Salix?
6.3.1 Synergy Pharmaceuticals ?Salix? Corporation Information
6.3.2 Synergy Pharmaceuticals ?Salix? Description and Business Overview
6.3.3 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Product Portfolio
6.3.5 Synergy Pharmaceuticals ?Salix? Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Novartis Oral Peptide Therapy Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Chiasma
6.5.1 Chiasma Corporation Information
6.5.2 Chiasma Description and Business Overview
6.5.3 Chiasma Oral Peptide Therapy Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Chiasma Oral Peptide Therapy Product Portfolio
6.5.5 Chiasma Recent Developments/Updates
7 Oral Peptide Therapy Manufacturing Cost Analysis
7.1 Oral Peptide Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oral Peptide Therapy
7.4 Oral Peptide Therapy Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oral Peptide Therapy Distributors List
8.3 Oral Peptide Therapy Customers
9 Oral Peptide Therapy Market Dynamics
9.1 Oral Peptide Therapy Industry Trends
9.2 Oral Peptide Therapy Market Drivers
9.3 Oral Peptide Therapy Market Challenges
9.4 Oral Peptide Therapy Market Restraints
10 Global Market Forecast
10.1 Oral Peptide Therapy Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oral Peptide Therapy by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Oral Peptide Therapy by Type (2023-2028)
10.2 Oral Peptide Therapy Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oral Peptide Therapy by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Oral Peptide Therapy by Application (2023-2028)
10.3 Oral Peptide Therapy Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oral Peptide Therapy by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Oral Peptide Therapy by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oral Peptide Therapy Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Oral Peptide Therapy Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Oral Peptide Therapy Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Oral Peptide Therapy Market Competitive Situation by Manufacturers in 2021
Table 5. Global Oral Peptide Therapy Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Oral Peptide Therapy Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Oral Peptide Therapy Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Oral Peptide Therapy Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Oral Peptide Therapy Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Oral Peptide Therapy Manufacturing Sites and Area Served
Table 11. Manufacturers Oral Peptide Therapy Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oral Peptide Therapy by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Peptide Therapy as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Oral Peptide Therapy Sales by Region (2017-2022) & (Units)
Table 16. Global Oral Peptide Therapy Sales Market Share by Region (2017-2022)
Table 17. Global Oral Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Oral Peptide Therapy Revenue Market Share by Region (2017-2022)
Table 19. North America Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 20. North America Oral Peptide Therapy Sales Market Share by Country (2017-2022)
Table 21. North America Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Oral Peptide Therapy Revenue Market Share by Country (2017-2022)
Table 23. Europe Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 24. Europe Oral Peptide Therapy Sales Market Share by Country (2017-2022)
Table 25. Europe Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Oral Peptide Therapy Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Oral Peptide Therapy Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Oral Peptide Therapy Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Oral Peptide Therapy Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Oral Peptide Therapy Revenue Market Share by Region (2017-2022)
Table 31. Latin America Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 32. Latin America Oral Peptide Therapy Sales Market Share by Country (2017-2022)
Table 33. Latin America Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Oral Peptide Therapy Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Oral Peptide Therapy Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Oral Peptide Therapy Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Oral Peptide Therapy Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Oral Peptide Therapy Revenue Market Share by Country (2017-2022)
Table 39. Global Oral Peptide Therapy Sales by Type (2017-2022) & (Units)
Table 40. Global Oral Peptide Therapy Sales Market Share by Type (2017-2022)
Table 41. Global Oral Peptide Therapy Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Oral Peptide Therapy Revenue Share by Type (2017-2022)
Table 43. Global Oral Peptide Therapy Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Oral Peptide Therapy Sales (Units) by Application (2017-2022)
Table 45. Global Oral Peptide Therapy Sales Market Share by Application (2017-2022)
Table 46. Global Oral Peptide Therapy Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Oral Peptide Therapy Revenue Share by Application (2017-2022)
Table 48. Global Oral Peptide Therapy Price by Application (2017-2022) & (US$/Unit)
Table 49. Allergan Corporation Information
Table 50. Allergan Description and Business Overview
Table 51. Allergan Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Allergan Oral Peptide Therapy Product
Table 53. Allergan Recent Developments/Updates
Table 54. Novo Nordisk Corporation Information
Table 55. Novo Nordisk Description and Business Overview
Table 56. Novo Nordisk Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Novo Nordisk Oral Peptide Therapy Product
Table 58. Novo Nordisk Recent Developments/Updates
Table 59. Synergy Pharmaceuticals ?Salix? Corporation Information
Table 60. Synergy Pharmaceuticals ?Salix? Description and Business Overview
Table 61. Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Synergy Pharmaceuticals ?Salix? Oral Peptide Therapy Product
Table 63. Synergy Pharmaceuticals ?Salix? Recent Developments/Updates
Table 64. Novartis Corporation Information
Table 65. Novartis Description and Business Overview
Table 66. Novartis Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Novartis Oral Peptide Therapy Product
Table 68. Novartis Recent Developments/Updates
Table 69. Chiasma Corporation Information
Table 70. Chiasma Description and Business Overview
Table 71. Chiasma Oral Peptide Therapy Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Chiasma Oral Peptide Therapy Product
Table 73. Chiasma Recent Developments/Updates
Table 74. Production Base and Market Concentration Rate of Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Oral Peptide Therapy Distributors List
Table 77. Oral Peptide Therapy Customers List
Table 78. Oral Peptide Therapy Market Trends
Table 79. Oral Peptide Therapy Market Drivers
Table 80. Oral Peptide Therapy Market Challenges
Table 81. Oral Peptide Therapy Market Restraints
Table 82. Global Oral Peptide Therapy Sales Forecast by Type (2023-2028) & (Units)
Table 83. Global Oral Peptide Therapy Sales Market Share Forecast by Type (2023-2028)
Table 84. Global Oral Peptide Therapy Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 85. Global Oral Peptide Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 86. Global Oral Peptide Therapy Sales Forecast by Application (2023-2028) & (Units)
Table 87. Global Oral Peptide Therapy Sales Market Share Forecast by Application (2023-2028)
Table 88. Global Oral Peptide Therapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. Global Oral Peptide Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 90. Global Oral Peptide Therapy Sales Forecast by Region (2023-2028) & (Units)
Table 91. Global Oral Peptide Therapy Sales Market Share Forecast by Region (2023-2028)
Table 92. Global Oral Peptide Therapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 93. Global Oral Peptide Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Peptide Therapy
Figure 2. Global Oral Peptide Therapy Market Share by Type in 2021 & 2028
Figure 3. Linaclotide Product Picture
Figure 4. Insulin Product Picture
Figure 5. Plecanatide Product Picture
Figure 6. Cyclosporine Product Picture
Figure 7. Octreotide Product Picture
Figure 8. Global Oral Peptide Therapy Market Share by Application in 2021 & 2028
Figure 9. Hospital
Figure 10. Retail Pharmacy
Figure 11. Global Oral Peptide Therapy Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Oral Peptide Therapy Market Size (2017-2028) & (US$ Million)
Figure 13. Global Oral Peptide Therapy Sales (2017-2028) & (Units)
Figure 14. Oral Peptide Therapy Sales Share by Manufacturers in 2021
Figure 15. Global Oral Peptide Therapy Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Oral Peptide Therapy Players: Market Share by Revenue in 2021
Figure 17. Oral Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Oral Peptide Therapy Sales Market Share by Region (2017-2022)
Figure 19. Global Oral Peptide Therapy Sales Market Share by Region in 2021
Figure 20. Global Oral Peptide Therapy Revenue Market Share by Region (2017-2022)
Figure 21. Global Oral Peptide Therapy Revenue Market Share by Region in 2021
Figure 22. United States Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China Taiwan Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Oral Peptide Therapy Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Oral Peptide Therapy by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Oral Peptide Therapy
Figure 46. Manufacturing Process Analysis of Oral Peptide Therapy
Figure 47. Oral Peptide Therapy Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Industry Market Size
